SSRIs and Osteoporosis
Some recently published studies suggest that taking selective serotonin reuptake inhibitors (SSRIs) may increase the risk of developing osteoporosis. A relationship between SSRIs and osteoporosis is biologically plausible because bone has serotonin receptors, and SSRI-treated mice have reduced bone mass....
Cannot Access - We are sorry, but you cannot access the requested article.
If you have already purchased this article, or have a subscription to The Medical Letter on Drugs and Therapeutics, please login or register to view it online.
If you have already purchased this article, or have a subscription to The Medical Letter on Drugs and Therapeutics, please login or register to view it online.
Information about the article:
Title: SSRIs and Osteoporosis
Publication: The Medical Letter on Drugs and Therapeutics
Issue #: 1274
Article Code: 1274c
Date: November 19, 2007
Volume: 49
Pages: 95-96
Publication: The Medical Letter on Drugs and Therapeutics
Issue #: 1274
Article Code: 1274c
Date: November 19, 2007
Volume: 49
Pages: 95-96
Subscribe to The Medical Letter on Drugs and Therapeutics for instant access to this article. Add this downloadable, electronic article to your cart (U.S. English version only)